When a public figure is diagnosed with a serious illness, it often brings quiet health issues into the spotlight. That’s exactly what happened on May 18, when former President Joe Biden’s office confirmed he has been diagnosed with an aggressive form of prostate cancer. The cancer, described as hormone-sensitive with metastasis to the bone, is serious but treatable—a distinction that matters for anyone trying to understand what this means, both for him and for others facing similar news.
Prostate cancer is one of the most common cancers in men, but it often goes undetected until symptoms become disruptive or the disease has advanced. Biden’s diagnosis is a stark reminder of how important early detection, symptom awareness, and individualized care are—especially for older adults. It also opens the door for a broader conversation about what “aggressive” prostate cancer really means, how it’s treated, and what practical steps men can take to stay ahead of it.
What We Know About Joe Biden’s Case
On May 18, former President Joe Biden’s office confirmed he has been diagnosed with an “aggressive form” of prostate cancer. The official statement specified that he was evaluated after experiencing worsening urinary symptoms. His medical team discovered a prostate nodule, and subsequent testing confirmed a Gleason score of 9, classified as Grade Group 5, with metastasis to the bone.
This kind of diagnosis is considered advanced. A Gleason score of 9 is at the high end of the scale used to assess how abnormal cancer cells look under a microscope, which helps predict how quickly the cancer is likely to grow and spread. Grade Group 5 represents the most serious category, indicating a fast-growing cancer with a higher risk of spreading beyond the prostate.
Metastasis to the bone means the cancer has already spread, which places it in a more advanced stage (Stage IV). However, the statement from Biden’s office noted that the cancer is “hormone-sensitive,” which is a critical detail. Hormone-sensitive prostate cancer responds to therapies that lower or block testosterone, a hormone that fuels the growth of many prostate cancers. This opens the door to treatment options that can significantly slow the disease, even in its aggressive form.
While the term “aggressive” can sound alarming, it’s important to understand that it doesn’t always equate to hopelessness. In the case of hormone-sensitive metastatic prostate cancer, a combination of hormone therapy and possibly other treatments—like chemotherapy, radiotherapy, or newer targeted drugs—can often help manage the disease effectively for several years.
This diagnosis also draws attention to the reality that prostate cancer, even when caught late, isn’t always untreatable. The key lies in how the cancer behaves biologically and how it responds to available treatments. Biden’s public disclosure brings visibility to a condition that affects roughly 1 in 8 men in the U.S. during their lifetime, according to the American Cancer Society.
Why Age Plays a Critical Role in Prostate Cancer Outcomes
Joe Biden’s diagnosis at age 82 puts a spotlight on how prostate cancer presents and is managed in older adults. Age is one of the biggest risk factors for prostate cancer. According to the American Cancer Society, about 60% of prostate cancers in the U.S. are diagnosed in men over the age of 65. While cancer in this age group is common, treatment decisions can be more complex.
Older adults are more likely to have other health issues, which can impact the choice and effectiveness of treatment. For example, aggressive treatments like chemotherapy or surgery carry higher risks of complications in someone over 80. That’s why doctors often weigh life expectancy, overall health, and how fast the cancer is likely to grow before recommending a treatment plan.
In Biden’s case, the cancer is not only aggressive but has also spread to the bone. That changes the approach significantly. Instead of curative treatment, the focus typically shifts to controlling the disease, relieving symptoms, and preserving quality of life. The fact that his cancer is hormone-sensitive is a positive sign—it means hormone therapy can play a central role in slowing progression.
For older adults, prostate cancer isn’t always treated immediately. In cases of slow-growing cancer, active surveillance—monitoring the disease without immediate treatment—might be recommended. But in Biden’s situation, the combination of a high Gleason score and metastasis makes early treatment essential, despite his age.
This also underscores the importance of recognizing symptoms, even later in life. Biden sought evaluation after experiencing “increasing urinary symptoms.” For many men, symptoms like difficulty urinating, a weak stream, or frequent nighttime urination can be early warning signs. Too often, these are dismissed as part of aging. In reality, they can signal something more serious—and in some cases, catching it earlier can change the outcome.
The Critical Difference in Biden’s Cancer
The statement from Joe Biden’s office emphasized that his cancer is “hormone-sensitive,” a key detail that shapes how it can be managed. Hormone-sensitive prostate cancer means the disease still responds to therapies that lower or block male hormones, especially testosterone, which fuel the growth of prostate cancer cells.
This is the foundation of androgen deprivation therapy (ADT), the standard first-line treatment for hormone-sensitive prostate cancer. ADT can be delivered through medications or surgical castration (orchiectomy), though the former is more common today. These drugs work by reducing testosterone levels or blocking its action on cancer cells, which can slow the disease significantly, even when it has spread.
In many cases, ADT is combined with other therapies to improve outcomes. For example, men with metastatic hormone-sensitive prostate cancer often receive ADT in combination with:
- Docetaxel, a chemotherapy drug shown to extend survival when added to hormone therapy.
- Androgen receptor inhibitors like enzalutamide or apalutamide, which block the ability of cancer cells to use testosterone even at low levels.
- Targeted radiation therapy, which can be used to relieve symptoms caused by bone metastases or reduce tumor burden in specific areas.
A 2022 study in The New England Journal of Medicine found that combining hormone therapy with drugs like enzalutamide increased survival compared to hormone therapy alone. These combination treatments are now becoming more common, especially in patients like Biden who are dealing with aggressive or metastatic disease.
Still, treatments come with trade-offs. ADT and related therapies can lead to side effects like fatigue, hot flashes, loss of muscle mass, and increased risk of cardiovascular issues. In older patients, doctors must balance these risks with the potential benefits. The goal isn’t just to prolong life—it’s also to maintain quality of life for as long as possible.
Recognizing the Red Flags of Prostate Cancer
Joe Biden’s diagnosis has stirred public interest not just because of his status, but because it highlights an important question: when should men get checked for prostate cancer, and what symptoms should prompt concern?
Routine prostate cancer screening is still debated in the medical community, but there are general guidelines. The U.S. Preventive Services Task Force recommends that men aged 55 to 69 talk to their doctor about the potential benefits and risks of prostate-specific antigen (PSA) testing. For men over 70, routine screening is not usually recommended, unless there are specific risk factors.
That said, screening is often the only way to catch prostate cancer early. The PSA blood test can detect elevated levels of a protein produced by the prostate, which may indicate cancer, though it’s not cancer-specific and can be elevated for other reasons like infection or benign prostatic hyperplasia (BPH).
Symptoms don’t usually appear in early-stage prostate cancer, which is why regular check-ups are important. When symptoms do develop, they can include:
- Trouble starting or stopping urination
- Weak or interrupted urine stream
- Frequent urination, especially at night
- Pain or burning during urination or ejaculation
- Blood in urine or semen
- Pain in the back, hips, or pelvis, especially if the cancer has spread
Men with a family history of prostate cancer, particularly if diagnosed before age 65, or those of African American descent, are at higher risk and should consider earlier discussions with their doctor—sometimes as early as age 40–45.
The American Cancer Society recommends that men at average risk begin that conversation around age 50. But ultimately, it’s not just about age. If something feels off—changes in urination, unexplained bone pain, or anything persistent—it’s worth bringing up. Biden’s example makes this clear: even at 82, symptoms matter, and acting on them can lead to diagnosis and intervention.
Don’t Wait to Prioritize Your Health
Joe Biden’s cancer diagnosis is a reminder that health vigilance doesn’t end with age, status, or success. It underscores the importance of listening to your body, acting on symptoms early, and having honest conversations with healthcare providers about risks—especially for conditions like prostate cancer that can progress quietly.
This is not just a story about a former president. It’s a reality check for millions of men who may ignore symptoms or delay screenings. Too often, men dismiss early warning signs—frequent urination, back pain, fatigue—as part of “getting older.” But as Biden’s case shows, these signs can sometimes point to something more serious.
If you’re a man over 50—or younger with risk factors—this is the time to take action:
- Book a primary care visit. Even if you feel fine, a routine check-in can catch potential issues early.
- Ask about prostate screening. Discuss the pros and cons of PSA testing with your doctor based on your personal risk.
- Don’t ignore symptoms. If you notice changes in urination, bone pain, or persistent fatigue, speak up.
- Support others. Encourage the men in your life to do the same. Conversations about health, especially among men, often don’t happen until it’s too late.
Finally, access to help matters. If you or someone you know is dealing with a recent diagnosis or has questions about prostate cancer, the American Cancer Society offers 24/7 support at 1-800-227-2345 and through live chat on their website. You don’t have to navigate it alone.
